[HTML] frontiersin.org

[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) independently predicts severity and length of hospitalisation in patients with COVID-19

H Enocsson, C Idoff, A Gustafsson, M Govender… - Frontiers in …, 2021 - frontiersin.org
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …
被引用次数：38 相关文章

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

H Enocsson, C Idoff, A Gustafsson… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19.

H Enocsson, C Idoff, A Gustafsson, M Govender… - Frontiers in …, 2021 - europepmc.org
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …
[PDF] scienceopen.com

[PDF][PDF] Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

H Enocsson, C Idoff, A Gustafsson, M Govender… - scienceopen.com
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …
[HTML] nih.gov

[HTML][HTML] Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

H Enocsson, C Idoff, A Gustafsson… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

H Enocsson, C Idoff, A Gustafsson, M Govender… - Frontiers in …, 2021 - diva-portal.org
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

H Enocsson, C Idoff, A Gustafsson… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …